GOSS vs REG · rev $114.7M vs P/E 34, $12.93B cap
Gossamer Bio Inc (GOSS) versus Regency Centers Corporation (REG) — a side-by-side from cached financials, not a winner call.
Gossamer Bio Inc (GOSS) is a biotechnology company listed on US.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
Latest reported GOSS revenue for 2024-12-31 was $114.7M. Net income was -$56.5M. GOSS currently screens at market cap $47.0M.
REG does not have a complete income-statement cache yet.
GOSS currently screens at market cap $47.0M. REG currently screens at market cap $12.93B and trailing P/E 33.5.
Not investment advice. Open the GOSS and REG stock pages for the full models.
Not investment advice.